NSE filing, NSE: UPL. Summary written from the filing by ALFA Finder's alert engine.
UPL Ltd: key numbers
- Share price
- ₹513.35
- Market cap
- ₹43,335 Cr
- Revenue (annual)
- ₹51,839 Cr
- Net profit (annual)
- ₹1,922 Cr
- P/E (TTM)
- 22.5×Sector 34.1×
- Promoter holding
- 33.51%+0.00% QoQ
- FII holding
- 42.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from UPL Ltd
All →UPL Management Change
UPL's board appointed S R B C & CO LLP as auditors, LIC-nominated Director Shrivastava, and President Tandon to senior management. All effective November 2, 2026.
UPL Investor Presentation: Key Takeaways
Q2FY27 revenue ₹11,860 cr (-1%), EBITDA ₹2,312 cr (+5%, 19.5% margin); H1 Operational PATMI ₹441 cr (+33%). Eight quarters of margin expansion; Advanta acquiring Misr Hytech.
UPL Q2 FY27 Results: Net Profit ₹452 Cr, Down 26.1% YoY
UPL Ltd reported revenue from operations of ₹11,860 Cr (-1.3% YoY) and net profit of ₹452 Cr (-26.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹452 Cr · -26.1% YoY
UPL Board Meeting Date
UPL schedules a 2 November 2026 board meeting to approve unaudited quarterly and half-year results, followed by an earnings call. The trading window stays closed until 48 hours after results are disseminated.
UPL Other Announcement
UPL Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
UPL Credit Rating
CRISIL Ratings has revised UPL Limited's long-term bank facility outlook from 'Negative' to 'Stable', while reaffirming its 'CRISIL AA+' rating.
Other results update announcements
All →Wonderla Holidays Results Update
Wonderla reports best-ever Q2 with 42% income growth to ₹126 Cr and 90% EBITDA growth. H1 income up 41% to ₹378 Cr driven by new Chennai park.
Procter & Gamble Health Results Update
P&G Health's Q2 sales grew 18% to ₹376 crore and PAT rose 26% to ₹112 crore. Growth driven by brand strength and retail execution.
JTL Defence Results Update
JTL Defence reported H1 FY27 revenue of Rs.410 Cr, up 11.4x YoY, with EBITDA of Rs.47 Cr. Adjusted PAT of Rs.3 Cr was impacted by asset revaluation depreciation.
Mold-Tek Packaging Results Update
Mold-Tek reported Q2 FY27 net profit up 36% to Rs 21.06 Cr and H1 profit up 23% to Rs 46.67 Cr. Revenue and sales volumes also rose across both periods.
Epigral Results Update
Epigral reported Q2 FY27 PAT of ₹64 Cr, up 26% YoY, with revenue at ₹752 Cr. EBITDA margin was 18% despite elevated raw material costs.
Eureka Forbes Results Update
Eureka Forbes reported Q2 FY27 revenue of ₹889.6 Cr and PAT of ₹73.3 Cr, both up ~19% YoY. EBITDA margin hit a lifetime high of 13.6%.